OECD TG 420
OECD TG 420 is the standard ‘Acute Oral Toxicity – Fixed Dose Procedure (FDP)’, i.e. Acute Oral Toxicity – Fixed Dose Procedure, which is listed under Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. It was first adopted in 1992 and updated in 2001. The test is an in vivo toxicity test designed to assess the acute toxic effects of a substance following a single oral administration.
The main objective of OECD TG 420 is to determine the substance’s acute oral toxicity potential and its GHS/CLP classification, whilst using fewer animals than in the traditional LD50 determination approach and prioritising animal welfare. Consequently, the method does not seek to determine an exact LD50 value, but is based on a classification derived from the clear signs of toxicity observed at fixed doses.
The basic principle of the test is as follows:
- The test substance is administered orally to the animals at specific fixed doses (usually 5, 50, 300 and 2000 mg/kg body weight).
- The substance is usually administered to rats as a single dose in a suitable vehicle.
- The animals are kept under clinical observation for at least 14 days; during this period, signs of toxicity, reversibility, changes in body weight and mortality are recorded.
- At the end of the study, a post-mortem examination is carried out and the macroscopic findings are documented.
- The procedure consists of a preliminary study (sighting study) and a subsequent main study; the preliminary study helps to determine the appropriate starting dose and to avoid the unnecessary use of animals.
The key features of the process are:
- Fixed dosage levels: 5, 50, 300 and 2000 mg/kg
- The concept of ‘evident toxicity’: rather than death, the observation of serious and irreversible toxic effects is taken as the basis
- A stepwise approach: Depending on the toxicity findings, the dosage level is adjusted; it is not necessary to test all dosage levels
- Reduction in the number of animals: Significantly fewer animals are used compared with conventional LD50 tests
- GHS/CLP classification: The results obtained are used to determine the categories of acute oral toxicity
The key parameters reported in the study are:
- Dose levels used (mg/kg)
- Clinical observations and their onset
- Changes in body weight
- Mortality and survival times
- Post-mortem findings
- Dose level at which marked toxicity was observed
- GHS/CLP category for acute oral toxicity and justification for the classification
- Animal species used, sex, age, experimental material and conditions of use
- Data on measurement uncertainty and repeatability
Why is it carried out?
The OECD TG 420 is being carried out for the following scientific and regulatory purposes:
- Definition of acute oral toxicity: the determination of the toxic effects and target organs that occur following a single oral exposure
- GHS/CLP classification: Determination of the substance’s acute oral toxicity category and specification of labelling requirements
- Prioritisation of animal welfare (3Rs): reduction in the number of animals used compared with conventional LD50 tests and minimisation of severe pain and suffering
- Support with regulatory documentation: Use in safety assessments of chemicals, pesticides, biocidal products, medicinal products and medical devices
- Contribution to risk assessment: Provision of baseline data for risk assessment in acute exposure scenarios
- Prioritisation: Reviewing a large number of substances and setting priorities for further testing
- Labelling and transport: Data on acute oral toxicity are used in the classification of chemicals for the purposes of labelling and transport
- Evidence-based approach: A contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data
OECD TG 420 zielt nicht darauf ab, einen eindeutigen LD50-Wert zu ermitteln; stattdessen liefert sie eine Einstufung auf der Grundlage eindeutiger Toxizitätsbefunde. Die Ergebnisse sollten im Zusammenhang mit der chemischen Struktur der Substanz, anderen Daten zur akuten Toxizität (z. B. TG 423, TG 425), der Toxizität bei wiederholter Verabreichung sowie der Expositionsbewertung interpretiert werden.
As part of our nano-testing services, we carry out acute oral toxicity studies in accordance with OECD TG 420, applying scientific rigour and utilising our accredited laboratory facilities and quality management system. Our scope of services includes the following:
Study design and protocol development
Preparation of a test report in accordance with OECD TG 420
Scientific justification for the starting dose and dose levels, based on the physicochemical properties of the test substance and the available toxicity data
Selection of a suitable carrier (vehicle) and assessment of solubility and stability
Determination of animal species, sex, age and administration conditions
- Compliance with ethical approval and animal welfare requirements
- Where appropriate, design of a preliminary trial (sighting study)
For your acute oral toxicity studies in accordance with OECD TG 420, you can contact Nano-Test to obtain information on study design, dose determination, suitability of the vehicle, sample acceptance criteria, timetable and reporting procedures.

